Open access
Sep 2026
Sex-based survival disparities in patients with stage I–III non-small cell lung cancer vary by treatment modality
Introduction Female sex is a well-established prognostic factor in non-small cell lung cancer (NSCLC). Most prior studies are restricted to single-treatment cohorts and seldom include best supportive care (BSC), limiting the evaluation of sex-based median overall survival across the full treatment spectrum, BSC include...
G. V. D. van den Heuvel, B. Mandos, Hans J. M. Smit et al.
· Frontiers in Oncology · 0 citations